Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011:7:495-500.
doi: 10.2147/TCRM.S16415. Epub 2011 Dec 8.

The effect of hyoscine butylbromide in shortening the first stage of labor: A double blind, randomized, controlled, clinical trial

Nourah H Al Qahtani  1 , Fatma Al Hajeri
Affiliations

The effect of hyoscine butylbromide in shortening the first stage of labor: A double blind, randomized, controlled, clinical trial

Nourah H Al Qahtani et al. Ther Clin Risk Manag. 2011.

Abstract

Background and objectives: Hyoscine butylbromide (HBB) is widely used in labor rooms. There have been many studies on the use of HBB during labor with conflicting results, involving both primiparous and multiparous women. The aim of this trial was to study the efficacy of HBB for shortening the first stage of labor in primiparous women.

Methods: The study was a randomized, double blind, controlled trial. Ninety-seven primigravid term pregnant women in spontaneous labor received either hyoscine butylbromide or a placebo intramuscularly once the women entered the active phase of labor. The primary outcome measured was the duration of the first stage of labor. Secondary outcomes were the duration of the second and third stages of labor, blood loss at delivery, rate of cesarean section, and Apgar scores for the neonates.

Results: A total of 97 women yielded data for analysis. Of these, 45 women received the placebo and 52 received HBB. The mean duration of the first stage in the control group was 215 minutes, compared with 165 minutes in the study group, representing a decrease of 23.3% (P = 0.001). There were no significant changes in the duration of the second (P = 0.063) or third (P = 0.0418) stages of labor, and no significant differences in blood loss or Apgar scores. There was a slightly higher (but statistically insignificant) rate of instrumental delivery in the control group, but no difference in the Cesarean section rate. There was a 60% reduction in opioid analgesic use in the HBB group.

Conclusion: HBB is effective in significantly reducing the duration of the first stage of labor, and is not associated with any apparent adverse maternal or neonatal outcomes.

Keywords: augmentation; duration; first stage; hyoscine butylbromide; labor.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Mean durations of the first, second, and third stages of labor in the control group (group 2) and the hyoscine butylbromide group (group 1). Notes: Vertical bars denote 0.95% confidence intervals. *P < 0.001 indicates a significant difference between the hyoscine butylbromide and control groups.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Lopez-Zeno JA, Peaceman AM, Adashek JA, Socol ML. A controlled trial of a program for the active management of labour. N Engl J Med. 1992;326:450–454. - PubMed
    1. Frigoletto FD, Jr, Lieberman E, Lang JM, et al. A clinical trial of active management of labour. N Engl J Med. 1995;333:745–750. - PubMed
    1. Sadler LC, Davison T, McCowan LM. A randomised controlled trial and meta-analysis of active management of labour. BJOG. 2000;107(7):909–915. - PubMed
    1. Hotwani J, Ainapure SS. Hyoscine butylbromide suppositories. Indian Medical Gaz. 2000:217–219.
    1. Corsen G. A study of the use and mode of action of the antispasmodic drug Buscopan in gynecology and obstetrics. Med Klin. 1983;48:2186–2188.